211 related articles for article (PubMed ID: 31651965)
1. Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer.
Vaske OM; Bjork I; Salama SR; Beale H; Tayi Shah A; Sanders L; Pfeil J; Lam DL; Learned K; Durbin A; Kephart ET; Currie R; Newton Y; Swatloski T; McColl D; Vivian J; Zhu J; Lee AG; Leung SG; Spillinger A; Liu HY; Liang WS; Byron SA; Berens ME; Resnick AC; Lacayo N; Spunt SL; Rangaswami A; Huynh V; Torno L; Plant A; Kirov I; Zabokrtsky KB; Rassekh SR; Deyell RJ; Laskin J; Marra MA; Sender LS; Mueller S; Sweet-Cordero EA; Goldstein TC; Haussler D
JAMA Netw Open; 2019 Oct; 2(10):e1913968. PubMed ID: 31651965
[TBL] [Abstract][Full Text] [Related]
2. Data sharing for clinical utility.
Bjork I; Peralez J; Haussler D; Spunt SL; Vaske OM
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645349
[TBL] [Abstract][Full Text] [Related]
3. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
[TBL] [Abstract][Full Text] [Related]
4. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
[TBL] [Abstract][Full Text] [Related]
5. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
Mody RJ; Wu YM; Lonigro RJ; Cao X; Roychowdhury S; Vats P; Frank KM; Prensner JR; Asangani I; Palanisamy N; Dillman JR; Rabah RM; Kunju LP; Everett J; Raymond VM; Ning Y; Su F; Wang R; Stoffel EM; Innis JW; Roberts JS; Robertson PL; Yanik G; Chamdin A; Connelly JA; Choi S; Harris AC; Kitko C; Rao RJ; Levine JE; Castle VP; Hutchinson RJ; Talpaz M; Robinson DR; Chinnaiyan AM
JAMA; 2015 Sep; 314(9):913-25. PubMed ID: 26325560
[TBL] [Abstract][Full Text] [Related]
6. Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial.
Harttrampf AC; Lacroix L; Deloger M; Deschamps F; Puget S; Auger N; Vielh P; Varlet P; Balogh Z; Abbou S; Allorant A; Valteau-Couanet D; Sarnacki S; Gamiche-Rolland L; Meurice G; Minard-Colin V; Grill J; Brugieres L; Dufour C; Gaspar N; Michiels S; Vassal G; Soria JC; Geoerger B
Clin Cancer Res; 2017 Oct; 23(20):6101-6112. PubMed ID: 28733441
[No Abstract] [Full Text] [Related]
7. Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized Medicine.
Dupain C; Harttrampf AC; Boursin Y; Lebeurrier M; Rondof W; Robert-Siegwald G; Khoueiry P; Geoerger B; Massaad-Massade L
Mol Ther; 2019 Jan; 27(1):200-218. PubMed ID: 30509566
[TBL] [Abstract][Full Text] [Related]
8. Discovery of clinically relevant fusions in pediatric cancer.
LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory Cancer.
Goggin KP; Gonzalez-Pena V; Inaba Y; Allison KJ; Hong DK; Ahmed AA; Hollemon D; Natarajan S; Mahmud O; Kuenzinger W; Youssef S; Brenner A; Maron G; Choi J; Rubnitz JE; Sun Y; Tang L; Wolf J; Gawad C
JAMA Oncol; 2020 Apr; 6(4):552-556. PubMed ID: 31855231
[TBL] [Abstract][Full Text] [Related]
10. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Parsons DW; Janeway KA; Patton DR; Winter CL; Coffey B; Williams PM; Roy-Chowdhuri S; Tsongalis GJ; Routbort M; Ramirez NC; Saguilig L; Piao J; Alonzo TA; Berg SL; Fox E; Hawkins DS; Abrams JS; Mooney M; Takebe N; Tricoli JV; Seibel NL;
J Clin Oncol; 2022 Jul; 40(20):2224-2234. PubMed ID: 35353553
[TBL] [Abstract][Full Text] [Related]
11. Financial Loss for Inpatient Care of Medicaid-Insured Children.
Colvin JD; Hall M; Berry JG; Gottlieb LM; Bettenhausen JL; Shah SS; Fieldston ES; Conway PH; Chung PJ
JAMA Pediatr; 2016 Nov; 170(11):1055-1062. PubMed ID: 27618284
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.
Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY
PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416
[TBL] [Abstract][Full Text] [Related]
15. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
[TBL] [Abstract][Full Text] [Related]
16. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
[TBL] [Abstract][Full Text] [Related]
17. Using RNA sequencing for identifying gene imprinting and random monoallelic expression in human placenta.
Metsalu T; Viltrop T; Tiirats A; Rajashekar B; Reimann E; Kõks S; Rull K; Milani L; Acharya G; Basnet P; Vilo J; Mägi R; Metspalu A; Peters M; Haller-Kikkatalo K; Salumets A
Epigenetics; 2014 Oct; 9(10):1397-409. PubMed ID: 25437054
[TBL] [Abstract][Full Text] [Related]
18. Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer.
Newton Y; Rassekh SR; Deyell RJ; Shen Y; Jones MR; Dunham C; Yip S; Leelakumari S; Zhu J; McColl D; Swatloski T; Salama SR; Ng T; Hendson G; Lee AF; Ma Y; Moore R; Mungall AJ; Haussler D; Stuart JM; Jantzen C; Laskin J; Jones SJM; Marra MA; Morozova O
JCO Precis Oncol; 2018; 2():. PubMed ID: 31372595
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.
Tao K; Yamazaki F; Kubo T; Sunami K; Kumamoto T; Arakawa A; Sugiyama M; Watanabe Y; Nakajima M; Shirakawa N; Tanimura K; Koyama T; Hirata M; Sudo K; Tanabe N; Watanabe T; Yoshida T; Kitami M; Yoshida A; Yatabe Y; Nakano Y; Ohira M; Kamijo T; Nakazawa A; Kato M; Ichimura K; Kohno T; Yamamoto N; Hishiki T; Ichikawa H; Ogawa C
JCO Precis Oncol; 2023 Jul; 7():e2200266. PubMed ID: 37410973
[TBL] [Abstract][Full Text] [Related]
20. Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.
Dufresne A; Attignon V; Ferrari A; Tonon L; Boyault S; Tabone-Eglinger S; Cassier P; Trédan O; Corradini N; Vinceneux A; Swalduz A; Viari A; Chabaud S; Pérol D; Blay JY; Saintigny P
Cancer Med; 2024 Apr; 13(7):e7115. PubMed ID: 38553950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
